{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:17:46Z","timestamp":1787008666027,"version":"build-2736575974"},"reference-count":77,"publisher":"Oxford University Press (OUP)","issue":"18","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"China Scholarship Council and University Medical Center Groningen","award":["CSC202006170047"],"award-info":[{"award-number":["CSC202006170047"]}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-21-CE14-0051"],"award-info":[{"award-number":["ANR-21-CE14-0051"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMW","doi-asserted-by":"publisher","award":["09120012110057"],"award-info":[{"award-number":["09120012110057"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["MSCA-ITN-2020"],"award-info":[{"award-number":["MSCA-ITN-2020"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["953489"],"award-info":[{"award-number":["953489"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ENW NWO","award":["OCENW.M.22.034"],"award-info":[{"award-number":["OCENW.M.22.034"]}]},{"name":"ENW NWO","award":["OCENW.M.23.189"],"award-info":[{"award-number":["OCENW.M.23.189"]}]},{"DOI":"10.13039\/501100004362","name":"Swiss Heart Foundation","doi-asserted-by":"publisher","award":["FF22028"],"award-info":[{"award-number":["FF22028"]}],"id":[{"id":"10.13039\/501100004362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030_166391\/1"],"award-info":[{"award-number":["310030_166391\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016405","name":"European Atherosclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016405","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Competitive Grants for Young Researchers 2023","award":["760-2023-03"],"award-info":[{"award-number":["760-2023-03"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>In humans, reduced G-protein coupled receptor 146 (GPR146) expression is associated with reductions in both LDL and HDL cholesterol. While the effects on LDL cholesterol are mediated via the intracellular ERK\/SREBP2 pathway, the mechanism explaining how GPR146 affects HDL cholesterol levels remains to be unravelled.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Whole-body (Gpr146\u2212\/\u2212) and liver-specific Gpr146 knockout (Gpr146 LKO) mice were used to explore changes in HDL metabolism. Wild-type mice were treated with a MEK1 inhibitor to block ERK signalling. HDL uptake and post-translational modification of scavenger receptor class B1 (SR-B1) were studied in murine primary hepatocytes. Genetic variants in GPR146 and SCARB1 served as instruments to examine HDL size and composition in human cohort studies. Investigation in both Gpr146\u2212\/\u2212 and Gpr146 LKO mice revealed a 20% reduction in HDL cholesterol and a concomitant 30% increase in hepatic SR-B1 protein (without changes in Scarb1 mRNA). This increase was driven by a 2.2-fold increase in cell surface SR-B1 via a mechanism that appears independent of ERK. In vitro studies show that loss of GPR146 increases SR-B1-mediated selective uptake of HDL lipid and HDL protein. Consistently, carriers of a GPR146 variant associated with loss-of-function and carriers of SCARB1 gain-of-function variant share reductions in apoA-I, HDL particle size, HDL cholesterol, and cholesteryl ester content compared to non-carriers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study suggests that loss of GPR146 reduces HDL cholesterol via post-translational up-regulation of hepatic SR-B1 via an intracellular pathway that remains to be resolved. These findings imply that GPR146 inhibition to treat hypercholesterolaemia may not only lower plasma levels of LDL cholesterol but also HDL cholesterol.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cvr\/cvaf254","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:39:08Z","timestamp":1763645948000},"page":"2860-2872","source":"Crossref","is-referenced-by-count":2,"title":["Loss of GPR146 decreases plasma levels of HDL cholesterol via post-translational up-regulation of SR-B1 protein levels"],"prefix":"10.1093","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6653-0085","authenticated-orcid":false,"given":"Boyan","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University Medical Center Groningen, University of Groningen , Antonius Deusinglaan 1, Groningen 9713 AV ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Loaiza","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Medical Center Groningen, University of Groningen , Antonius Deusinglaan 1, Groningen 9713 AV ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Rimbert","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9, CNRS, INSERM, L\u2019institut du Thorax , F-44000 Nantes ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5900-1399","authenticated-orcid":false,"given":"Federico","family":"Oldoni","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Medical Center Groningen, University of Groningen , Antonius Deusinglaan 1, Groningen 9713 AV ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisanne L","family":"Blauw","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, and Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center , Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C N","family":"Rensen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, and Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center , Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent O","family":"Martinez","sequence":"additional","affiliation":[{"name":"LiMitAging, Institute of Metabolic and Cardiovascular Diseases, I2MC UMR1297, IHU HealthAge, INSERM, Universit\u00e9 de Toulouse, Toulouse University Hospital (CHU Toulouse) , Toulouse ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Robert","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry, University Hospital of Zurich and University of Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1666-2266","authenticated-orcid":false,"given":"Arnold","family":"von Eckardstein","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry, University Hospital of Zurich and University of Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justina Clarinda","family":"Wolters","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Medical Center Groningen, University of Groningen , Antonius Deusinglaan 1, Groningen 9713 AV ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolette","family":"Huijkman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Medical Center Groningen, University of Groningen , Antonius Deusinglaan 1, Groningen 9713 AV ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Kloosterhuis","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Medical Center Groningen, University of Groningen , Antonius Deusinglaan 1, Groningen 9713 AV ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Smit","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Medical Center Groningen, University of Groningen , Antonius Deusinglaan 1, Groningen 9713 AV ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"van de Sluis","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Medical Center Groningen, University of Groningen , Antonius Deusinglaan 1, Groningen 9713 AV ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Albert","family":"Kuivenhoven","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Medical Center Groningen, University of Groningen , Antonius Deusinglaan 1, Groningen 9713 AV ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4907-5017","authenticated-orcid":false,"given":"Umesh","family":"Tharehalli","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Medical Center Groningen, University of Groningen , Antonius Deusinglaan 1, Groningen 9713 AV ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"2026021404514176000_cvaf254-B1","doi-asserted-by":"crossref","first-page":"e012924","DOI":"10.1161\/JAHA.119.012924","article-title":"Cholesterol and atherosclerotic cardiovascular disease: a lifelong problem","volume":"8","author":"Gidding","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2026021404514176000_cvaf254-B2","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(20)32233-9","article-title":"Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70\u2013100 years: a contemporary primary prevention cohort","volume":"396","author":"Mortensen","year":"2020","journal-title":"Lancet"},{"key":"2026021404514176000_cvaf254-B3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12170-022-00694-y","article-title":"New strategies for lowering low-density lipoprotein cholesterol for cardiovascular disease prevention","volume":"16","author":"Gaine","year":"2022","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"2026021404514176000_cvaf254-B4","first-page":"1602","article-title":"2023: the year in cardiovascular disease\u2014the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?","volume":"19","author":"Banach","year":"2023","journal-title":"Arch Med Sci"},{"key":"2026021404514176000_cvaf254-B5","doi-asserted-by":"crossref","first-page":"106936","DOI":"10.1016\/j.phrs.2023.106936","article-title":"European guidelines for the treatment of dyslipidaemias: new concepts and future challenges","volume":"196","author":"Pirillo","year":"2023","journal-title":"Pharmacol Res"},{"key":"2026021404514176000_cvaf254-B6","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41586-021-04064-3","article-title":"The power of genetic diversity in genome-wide association studies of lipids","volume":"600","author":"Graham","year":"2021","journal-title":"Nature"},{"key":"2026021404514176000_cvaf254-B7","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Willer","year":"2013","journal-title":"Nat Genet"},{"key":"2026021404514176000_cvaf254-B8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0022-2275(20)32065-4","article-title":"Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions","volume":"41","author":"Packard","year":"2000","journal-title":"J Lipid Res"},{"key":"2026021404514176000_cvaf254-B9","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"key":"2026021404514176000_cvaf254-B10","doi-asserted-by":"crossref","first-page":"7134","DOI":"10.1073\/pnas.89.15.7134","article-title":"Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I","volume":"89","author":"Williamson","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026021404514176000_cvaf254-B11","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1073\/pnas.88.7.2793","article-title":"Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene","volume":"88","author":"Matsunaga","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026021404514176000_cvaf254-B12","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1172\/JCI200523915","article-title":"Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I","volume":"115","author":"Timmins","year":"2005","journal-title":"J Clin Invest"},{"key":"2026021404514176000_cvaf254-B13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s42003-019-0749-z","article-title":"Structural analysis of lecithin:cholesterol acyltransferase bound to high density lipoprotein particles","volume":"3","author":"Manthei","year":"2020","journal-title":"Commun Biol"},{"key":"2026021404514176000_cvaf254-B14","doi-asserted-by":"crossref","first-page":"26898","DOI":"10.1074\/jbc.M010708200","article-title":"The mechanism of the remodeling of high density lipoproteins by phospholipid transfer protein*","volume":"276","author":"Settasatian","year":"2001","journal-title":"J Biol Chem"},{"key":"2026021404514176000_cvaf254-B15","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1172\/JCI5578","article-title":"Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels","volume":"103","author":"Jiang","year":"1999","journal-title":"J Clin Invest"},{"key":"2026021404514176000_cvaf254-B16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0022-2275(20)41190-3","article-title":"Hepatic lipase promotes the uptake of HDL esterified cholesterol by the perfused rat liver: a study using reconstituted HDL particles of defined phospholipid composition","volume":"35","author":"Marques-Vidal","year":"1994","journal-title":"J Lipid Res"},{"key":"2026021404514176000_cvaf254-B17","doi-asserted-by":"crossref","first-page":"12485","DOI":"10.1038\/s41598-017-12882-7","article-title":"Impact of endothelial lipase on cholesterol efflux capacity of serum and high-density lipoprotein","volume":"7","author":"Schilcher","year":"2017","journal-title":"Sci Rep"},{"key":"2026021404514176000_cvaf254-B18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCRESAHA.113.300634","article-title":"Mendelian disorders of high-density lipoprotein metabolism","volume":"114","author":"Oldoni","year":"2014","journal-title":"Circ Res"},{"key":"2026021404514176000_cvaf254-B19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MOL.0b013e328350fad2","article-title":"Finding genes and variants for lipid levels after genome-wide association analysis","volume":"23","author":"Willer","year":"2012","journal-title":"Curr Opin Lipidol"},{"key":"2026021404514176000_cvaf254-B20","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/ng.3977","article-title":"Exome-wide association study of plasma lipids in &gt;300,000 individuals","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"key":"2026021404514176000_cvaf254-B21","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/s41588-018-0222-9","article-title":"Genetics of blood lipids among \u223c300,000 multi-ethnic participants of the Million Veteran Program","volume":"50","author":"Klarin","year":"2018","journal-title":"Nat Genet"},{"key":"2026021404514176000_cvaf254-B22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/pro.3307","article-title":"The human protein atlas: a spatial map of the human proteome","volume":"27","author":"Thul","year":"2018","journal-title":"Protein Sci"},{"key":"2026021404514176000_cvaf254-B23","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2019.10.034","article-title":"GPR146 deficiency protects against hypercholesterolemia and atherosclerosis","volume":"179","author":"Yu","year":"2019","journal-title":"Cell"},{"key":"2026021404514176000_cvaf254-B24","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/abbs\/gmaa058","article-title":"GPR146: an emerging therapeutic target for hypercholesterolemia and atherosclerosis","volume":"52","author":"She","year":"2020","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"2026021404514176000_cvaf254-B25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tem.2022.04.008","article-title":"Orphan GPR146: an alternative therapeutic pathway to achieve cholesterol homeostasis?","volume":"33","author":"Wilkins","year":"2022","journal-title":"Trends Endocrinol Metab"},{"key":"2026021404514176000_cvaf254-B26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41422-020-0303-z","article-title":"Hypercholesterolemia risk-associated GPR146 is an orphan G-protein coupled receptor that regulates blood cholesterol levels in humans and mice","volume":"30","author":"Han","year":"2020","journal-title":"Cell Res"},{"key":"2026021404514176000_cvaf254-B27","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.cell.2024.02.024","article-title":"A gut-derived hormone regulates cholesterol metabolism","volume":"187","author":"Hu","year":"2024","journal-title":"Cell"},{"key":"2026021404514176000_cvaf254-B28","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCRESAHA.117.312004","article-title":"The COMMD family regulates plasma LDL levels and attenuates atherosclerosis through stabilizing the CCC complex in endosomal LDLR trafficking","volume":"122","author":"Fedoseienko","year":"2018","journal-title":"Circ Res"},{"key":"2026021404514176000_cvaf254-B29","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/ATVBAHA.122.318169","article-title":"Cargo-specific role for retriever subunit VPS26C in hepatocyte lipoprotein receptor recycling to control postprandial triglyceride-rich lipoproteins","volume":"43","author":"Vos","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026021404514176000_cvaf254-B30","doi-asserted-by":"crossref","first-page":"W242","DOI":"10.1093\/nar\/gky354","article-title":"CRISPOR: intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens","volume":"46","author":"Concordet","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2026021404514176000_cvaf254-B31","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics"},{"key":"2026021404514176000_cvaf254-B32","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1161\/ATVBAHA.113.301363","article-title":"Interleukin 6 stimulates endothelial binding and transport of high-density lipoprotein through induction of endothelial lipase","volume":"33","author":"Robert","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026021404514176000_cvaf254-B33","first-page":"200","article-title":"A comparative microscopic and biochemical study of the uptake of fluorescent and 125I-labeled lipoproteins by skin fibroblasts, smooth muscle cells, and peritoneal macrophages in culture","volume":"121","author":"Reynolds","year":"1985","journal-title":"Am J Pathol"},{"key":"2026021404514176000_cvaf254-B34","doi-asserted-by":"crossref","first-page":"11122","DOI":"10.1038\/ncomms11122","article-title":"Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA","volume":"7","author":"Kettunen","year":"2016","journal-title":"Nat Commun"},{"key":"2026021404514176000_cvaf254-B35","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1039\/b910205a","article-title":"High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism","volume":"134","author":"Soininen","year":"2009","journal-title":"Analyst"},{"key":"2026021404514176000_cvaf254-B36","doi-asserted-by":"crossref","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"2026021404514176000_cvaf254-B37","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41467-023-36231-7","article-title":"Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank","volume":"14","author":"Julkunen","year":"2023","journal-title":"Nat Commun"},{"key":"2026021404514176000_cvaf254-B38","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hep.25648","article-title":"Liver phospholipid transfer protein (PLTP) expression with a PLTP-null background promotes very low-density lipoprotein production in mice","volume":"56","author":"Yazdanyar","year":"2012","journal-title":"Hepatology"},{"key":"2026021404514176000_cvaf254-B39","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1194\/jlr.M200166-JLR200","article-title":"Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion","volume":"43","author":"Lie","year":"2002","journal-title":"J Lipid Res"},{"key":"2026021404514176000_cvaf254-B40","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/ATVBAHA.122.317514","article-title":"Variants in the GPR146 gene are associated with a favorable cardiometabolic risk profile","volume":"42","author":"Rimbert","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026021404514176000_cvaf254-B41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-physiol-021317-121550","article-title":"SR-B1: a unique multifunctional receptor for cholesterol influx and efflux","volume":"80","author":"Shen","year":"2018","journal-title":"Annu Rev Physiol"},{"key":"2026021404514176000_cvaf254-B42","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/bi701277x","article-title":"Identification of the molecular target of small molecule inhibitors of HDL receptor SR-BI activity","volume":"47","author":"Nieland","year":"2008","journal-title":"Biochemistry"},{"key":"2026021404514176000_cvaf254-B43","doi-asserted-by":"crossref","first-page":"114270","DOI":"10.1016\/j.biopha.2023.114270","article-title":"Pharmacological inhibition of MEK1\/2 signaling disrupts bile acid metabolism through loss of Shp and enhanced Cyp7a1 expression","volume":"159","author":"Verzijl","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"2026021404514176000_cvaf254-B44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11883-022-01001-1","article-title":"SR-B1\u2019s Next top model: structural perspectives on the functions of the HDL receptor","volume":"24","author":"Powers","year":"2022","journal-title":"Curr Atheroscler Rep"},{"key":"2026021404514176000_cvaf254-B45","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1194\/jlr.R083121","article-title":"Thematic review series: lipid transfer proteins scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function","volume":"59","author":"Shen","year":"2018","journal-title":"J Lipid Res"},{"key":"2026021404514176000_cvaf254-B46","doi-asserted-by":"crossref","first-page":"13404","DOI":"10.1073\/pnas.0506679102","article-title":"Regulation of SR-BI protein levels by phosphorylation of its associated protein, PDZK1","volume":"102","author":"Nakamura","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026021404514176000_cvaf254-B47","doi-asserted-by":"crossref","first-page":"100616","DOI":"10.1016\/j.jbc.2021.100616","article-title":"The adaptor protein GIPC1 stabilizes the scavenger receptor SR-B1 and increases its cholesterol uptake","volume":"296","author":"Zhang","year":"2021","journal-title":"J Biol Chem"},{"key":"2026021404514176000_cvaf254-B48","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1194\/jlr.M200414-JLR200","article-title":"Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations","volume":"44","author":"Basso","year":"2003","journal-title":"J Lipid Res"},{"key":"2026021404514176000_cvaf254-B49","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1021\/acs.biochem.5b00180","article-title":"The effect of natural LCAT mutations on the biogenesis of HDL","volume":"54","author":"Fotakis","year":"2015","journal-title":"Biochemistry"},{"key":"2026021404514176000_cvaf254-B50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1194\/jlr.M600326-JLR200","article-title":"Regulation of SR-BI-mediated selective lipid uptake in Chinese hamster ovary-derived cells by protein kinase signaling pathways","volume":"48","author":"Zhang","year":"2007","journal-title":"J Lipid Res"},{"key":"2026021404514176000_cvaf254-B51","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.271.5248.518","article-title":"Identification of scavenger receptor SR-BI as a high density lipoprotein receptor","volume":"271","author":"Acton","year":"1996","journal-title":"Science"},{"key":"2026021404514176000_cvaf254-B52","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/387414a0","article-title":"Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels","volume":"387","author":"Kozarsky","year":"1997","journal-title":"Nature"},{"key":"2026021404514176000_cvaf254-B53","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.1074\/jbc.274.11.7165","article-title":"Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice","volume":"274","author":"Ueda","year":"1999","journal-title":"J Biol Chem"},{"key":"2026021404514176000_cvaf254-B54","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.aad3517","article-title":"Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease","volume":"351","author":"Zanoni","year":"2016","journal-title":"Science"},{"key":"2026021404514176000_cvaf254-B55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/01.ATV.0000149381.16166.c6","article-title":"Scavenger receptor class B type I mediates the selective uptake of high-density lipoprotein\u2013associated cholesteryl ester by the liver in mice","volume":"25","author":"Brundert","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026021404514176000_cvaf254-B56","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1194\/jlr.M500444-JLR200","article-title":"Hepatic SR-BI-mediated cholesteryl ester selective uptake occurs with unaltered efficiency in the absence of cellular energy","volume":"47","author":"Harder","year":"2006","journal-title":"J Lipid Res"},{"key":"2026021404514176000_cvaf254-B57","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature01250","article-title":"Ectopic \u03b2-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis","volume":"421","author":"Martinez","year":"2003","journal-title":"Nature"},{"key":"2026021404514176000_cvaf254-B58","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1161\/CIRCRESAHA.108.190587","article-title":"High-density lipoprotein transport through aortic endothelial cells involves scavenger receptor BI and ATP-binding cassette transporter G1","volume":"104","author":"Rohrer","year":"2009","journal-title":"Circ Res"},{"key":"2026021404514176000_cvaf254-B59","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1385\/CBB:41:3:343","article-title":"Visualization of the uptake of individual HDL particles in living cells via the scavenger receptor class B type I","volume":"41","author":"Rhode","year":"2004","journal-title":"Cell Biochem Biophys"},{"key":"2026021404514176000_cvaf254-B60","doi-asserted-by":"crossref","first-page":"11193","DOI":"10.1074\/jbc.M510261200","article-title":"SR-BI-mediated high density lipoprotein (HDL) endocytosis leads to HDL resecretion facilitating cholesterol efflux","volume":"281","author":"Pagler","year":"2006","journal-title":"J Biol Chem"},{"key":"2026021404514176000_cvaf254-B61","doi-asserted-by":"crossref","first-page":"8252","DOI":"10.1074\/jbc.RA120.013694","article-title":"Uptake of high-density lipoprotein by scavenger receptor class B type 1 is associated with prostate cancer proliferation and tumor progression in mice","volume":"295","author":"Traughber","year":"2020","journal-title":"J Biol Chem"},{"key":"2026021404514176000_cvaf254-B62","doi-asserted-by":"crossref","first-page":"25287","DOI":"10.1074\/jbc.M101726200","article-title":"High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion","volume":"276","author":"Silver","year":"2001","journal-title":"J Biol Chem"},{"key":"2026021404514176000_cvaf254-B63","doi-asserted-by":"crossref","first-page":"117200","DOI":"10.1016\/j.atherosclerosis.2023.117200","article-title":"Mapping the dynamic high-density lipoprotein synapse","volume":"380","author":"Frey","year":"2023","journal-title":"Atherosclerosis"},{"key":"2026021404514176000_cvaf254-B64","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.bbalip.2015.09.006","article-title":"Lipoprotein profiles in human heterozygote carriers of a functional mutation P297S in scavenger receptor class B1","volume":"1851","author":"Ljunggren","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"2026021404514176000_cvaf254-B65","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa0907687","article-title":"Genetic variant of the scavenger receptor BI in humans","volume":"364","author":"Vergeer","year":"2011","journal-title":"N Engl J Med"},{"key":"2026021404514176000_cvaf254-B66","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1194\/jlr.M800055-JLR200","article-title":"Scavenger receptor class B type I localizes to a late endosomal compartment","volume":"49","author":"Ahras","year":"2008","journal-title":"J Lipid Res"},{"key":"2026021404514176000_cvaf254-B67","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.devcel.2019.05.026","article-title":"Multimerization and retention of the scavenger receptor SR-B1 in the plasma membrane","volume":"50","author":"Marques","year":"2019","journal-title":"Dev Cell"},{"key":"2026021404514176000_cvaf254-B68","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1074\/jbc.M112.437368","article-title":"Regulation of expression and function of scavenger receptor class B, type I (SR-BI) by na+\/H+ exchanger regulatory factors (NHERFs)","volume":"288","author":"Hu","year":"2013","journal-title":"J Biol Chem"},{"key":"2026021404514176000_cvaf254-B69","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1073\/pnas.100114397","article-title":"Identification of a PDZ-domain-containing protein that interacts with the scavenger receptor class B type I","volume":"97","author":"Ikemoto","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026021404514176000_cvaf254-B70","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.bbrc.2017.06.175","article-title":"NHERF1 and NHERF2 regulation of SR-B1 stability via ubiquitination and proteasome degradation","volume":"490","author":"Lu","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"2026021404514176000_cvaf254-B71","first-page":"132","article-title":"GPR146 is a potential new therapeutic target for lipid lowering","volume":"17","author":"Fern\u00e1ndez-Ruiz","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2026021404514176000_cvaf254-B72","first-page":"22","article-title":"GPR146 inhibition protects against atherosclerosis","volume":"19","author":"Crunkhorn","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"2026021404514176000_cvaf254-B73","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1056\/NEJMe1706907","article-title":"Increasing lipolysis and reducing atherosclerosis","volume":"377","author":"Tall","year":"2017","journal-title":"N Engl J Med"},{"key":"2026021404514176000_cvaf254-B74","doi-asserted-by":"crossref","first-page":"32920","DOI":"10.1074\/jbc.273.49.32920","article-title":"Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice","volume":"273","author":"Wang","year":"1998","journal-title":"J Biol Chem"},{"key":"2026021404514176000_cvaf254-B75","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1172\/JCI25327","article-title":"Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo","volume":"115","author":"Zhang","year":"2005","journal-title":"J Clin Invest"},{"key":"2026021404514176000_cvaf254-B76","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1038\/s41591-023-02494-2","article-title":"RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts","volume":"29","author":"Watts","year":"2023","journal-title":"Nat Med"},{"key":"2026021404514176000_cvaf254-B77","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.tcm.2023.01.008","article-title":"ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases","volume":"34","author":"Luo","year":"2024","journal-title":"Trends Cardiovasc Med"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvaf254\/65465322\/cvaf254.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/121\/18\/2860\/65465322\/cvaf254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/121\/18\/2860\/65465322\/cvaf254.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:52:00Z","timestamp":1771062720000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/121\/18\/2860\/8340087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":77,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,11,21]]},"published-print":{"date-parts":[[2026,2,14]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvaf254","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,11,21]]}}}